SEK175.50
2.12% today
Stockholm, Apr 03, 05:29 pm CET
ISIN
SE0010323311
Symbol
BIOA B
Sector
Industry

BioArctic AB Stock price

SEK175.50
-47.50 21.30% 1M
+17.90 11.36% 6M
-24.00 12.03% YTD
-29.50 14.39% 1Y
+66.30 60.71% 3Y
+109.75 166.92% 5Y
+146.50 505.17% 10Y
Stockholm, Closing price Thu, Apr 03 2025
-3.80 2.12%
ISIN
SE0010323311
Symbol
BIOA B
Sector
Industry

Key metrics

Market capitalization SEK15.87b
Enterprise Value SEK15.41b
P/E (TTM) P/E ratio negative
EV/Sales (TTM) EV/Sales 59.90
P/S ratio (TTM) P/S ratio 61.68
P/B ratio (TTM) P/B ratio 17.71
Revenue growth (TTM) Revenue growth -58.22%
Revenue (TTM) Revenue SEK257.35m
EBIT (operating result TTM) EBIT SEK-229.62m
Cash position SEK512.93m
EPS (TTM) EPS SEK-2.00
P/E forward 16.21
P/S forward 8.60
EV/Sales forward 8.35
Show more

Is BioArctic AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

BioArctic AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a BioArctic AB forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a BioArctic AB forecast:

Buy
83%
Hold
17%

Financial data from BioArctic AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
257 257
58% 58%
100%
- Direct Costs 27 27
90% 90%
10%
230 230
33% 33%
90%
- Selling and Administrative Expenses 149 149
908% 908%
58%
- Research and Development Expense 311 311
247% 247%
121%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -230 -230
189% 189%
-89%
Net Profit -177 -177
177% 177%
-69%

In millions SEK.

Don't miss a Thing! We will send you all news about BioArctic AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

BioArctic AB engages in the research and development of modifying treatments and diagnostics for neurodegenerative diseases. Its research areas are Alzheimer’s disease and Parkinson’s disease where there are large unmet medical needs. The company was founded by Lars Gunnar Lannfelt and Pär Lars Gellerfors on January 24, 2003 and is headquartered in Stockholm, Sweden.

Head office Sweden
CEO Gunilla Osswald
Employees 107
Founded 2000
Website www.bioarctic.se

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today